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Introduction
!
Capsule endoscopy is a first-line investigative
modality for the small bowel that can be used to
obtain circumferential and often detailedmucosal
views of the narrow lumen during transit. [1–4]
It is noninvasive, does not require sedation, and
is much preferred by patients to intubational
endoscopy. [5] Intuitively, however, it seems like-
ly that the volume of the stomach, its collapsed
state when fasted, and unusual configuration will
hinder the ability of capsule endoscopy to reliably
identify pathology proximal to the small bowel.
However, we have shown that magnetically-assis-
ted capsule endoscopy (MACE) detects beads
sewn into all areas of an ex vivo water-containing
porcine stomach as reliably as conventional eso-
phagogastroduodenoscopy, implying that a de-
gree of control may allow a complete examina-
tion. [6] Preliminary human studies using mag-
nets to control capsule movement in fluid-filled
stomachs also suggest diagnostic yields that com-
pare favorably with esophagogastroduodenosco-
py. [7,8] Marelli et al., however, identified gastric
pathology using a capsule with a higher frame ac-
quisition rate and imaging devices at either end
(Pillcam Eso, Given Imaging, Yoqneam, Israel)
without using magnets or other methods of con-
trol and with much smaller ingestion volumes.
[9] This is consistent with studies of anemic pa-
tients having capsule endoscopy primarily to im-
age the small bowel (but providing some gastric
images during transit) identifying pathology in
the esophagus, stomach and duodenum, missed
by esophagogastroduodenoscopy, in up to 10% of
cases. [10,11] These data raise the question as to
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Background and study aims: Delayed gastric emp-
tying is a significant factor in incomplete small
bowel capsule examinations. Gastric transit could
be hastened by external magnetic control of the
capsule. We studied the feasibility of this ap-
proach to improve capsule endoscopy completion
rates.
Patients and methods: Prospective, single-center,
randomized controlled trial involving 122 pa-
tients attending for small bowel capsule endos-
copy using MiroCam Navi. Patients were random-
ized to either the control group (mobilisation for
30 minutes after capsule ingestion, followed by
intramuscular metoclopramide 10mg if the cap-
sule failed to enter the small bowel) or the inter-
vention group (1000mL of water prior to capsule
ingestion, followed by positional change and
magnetic steering). Outcome measures were cap-
sule endoscopy completion rate, gastric clarity
and distention, relationship of body habitus to
capsule endoscopy completion rate (CECR), and
patient comfort scores.
Results: 122 patients were recruited (61 each to
the control and intervention groups: mean age
49 years [range 21–85], 61 females). There was
no significant difference in CECR between the
two groups (P=0.39). Time to first pyloric image
was significantly shorter in the intervention
group (P=0.03) but there was no difference in
gastric transit times (P=0.12), suggesting that
magnetic control hastens capsular transit to the
gastric antrum but does not influence duodenal
passage. Gastric clarity and distention were sig-
nificantly better in the intervention group (P<
0.0001 and P<0.0001 respectively).
Conclusions: Magnetic steering of a small bowel
capsule is unable to overcome pyloric contrac-
tions to enhance gastric emptying and improve
capsule endoscope completion rate. Excellent
mucosal visualisation within the gastric cavity
suggests this technique could be harnessed for
capsule examination of the stomach.
whether the degree of control is sufficient to add significantly to
the diagnostic potential of this developing technology.
Transit of the capsule through the pylorus is easily recognized
and identification of the first duodenal image to mark the begin-
ning of the small bowel is standard practice during capsule
endoscopy reporting. By using this landmark, studies suggest
that delayed gastric emptying is a major factor in incomplete
small bowel capsule endoscopy examinations, which are thought
to occur in up to 30% of small bowel capsule endoscopy proce-
dures. [12,13] The use of prokinetics to stimulate gastric peristal-
sis has been shown to be effective in reducing gastric transit time
and improving CECR. [14,15] These medications carry a risk of
adverse reactions, parenteral administration is uncomfortable,
and a simple mechanical method that allows sufficient control
to steer the capsule into the small bowel may be a desirable alter-
native.
Understandably there has been an assumption in most trials that
volume distension of the stomach using swallowed water will al-
low visualisation of a greater surface area, act as a mucosal
cleansing agent, and provide a suitable medium in which a mag-
netically controlled capsule can move. Whether it is distension,
mucosal cleansing, purging or a combination of these actions,
preparation clearly improves mucosal visibility and improves di-
agnostic yields in small bowel capsule endoscopy. [16–19] Con-
trol of capsule movement in a stomach prepared to optimize dis-
tension and visibility may pave the way for noninvasive gastric
magnetically assisted capsule endoscopy (MACE).
In this study we have compared MACE with a standard protocol
to determine if control using a magnet can be demonstrated by
the achievement of a readily definable and, in terms of small
bowel examination, clinically useful endpoint: small bowel
CECR. We have compared two different preparation regimens in
terms of clarity of gastric mucosal images and distension to de-
termine if higher volume fluid ingestion improves the quality of
gastric visualisation.
Methods
!
Patients
Patients referred to our institution for small bowel capsule
endoscopy between February 2014 and February 2015 were invi-
ted to participate. Patients who were younger than age 20, preg-
nant, unable to speak or understand English or who had perma-
nent pacemakers, intracardiac devices or any other magnetically
or electrically controlled devices were excluded. Patient age, sex,
height, weight, waist-hip ratio, and body mass index (BMI) were
recorded. Small bowel capsule endoscopy was performed after a
12-hour fast and ingestion of 2L of polyethylene glycol during the
evening prior to the morning examination.
Procedures were performed using MiroCam Navi (Intromedic,
Seoul, Korea), a small bowel capsule endoscope containing mag-
netic inserts (dimensions 24×11mm, weight 4.2g, field of view
170°, depth of view 30mm, operation time 8 hours) (●" Fig.1).
Images acquired from one end are captured at a rate of 3 frames
per second and transmitted to a data recorder via electric field
propagation. These images can be viewed in real-time via a wire-
less connection to an iPad (Apple Inc., Cupertino, CA) and subse-
quently after downloading onto a computer workstation. Each
participant completed a numeric rating scale questionnaire
based on that used by Irvine et al [20] documenting their comfort
before and during their procedure, plus a statement as to wheth-
er they would be willing to undergo a repeat procedure.
Study design
This prospective, randomized controlled trial was approved by
the local institution and regional ethical review board (NRES
Committee Yorkshire & The Humber 14/YH/1010, Clinical trials
number: NCT0228). Patients were randomized using a comput-
er-generated random number sequence to enter one of two pro-
tocols:
1. Control protocol
The standard small bowel capsule endoscopy protocol at our
institution was used. The capsule was ingested using 200 mLs
of water with 5 drops of simethicone. Patients then mobilized
Fig.1 MiroCam Navi equipment.
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around the department for 30 minutes. The position of the
capsule was established using a real-time viewer. If the cap-
sule failed to enter the duodenum, metoclopramide (10mg in-
tramuscularly) was administered, followed by further mobili-
zation. If the capsule remained in the stomach after a further
30 minutes, an intravenous dose of erythromycin (250mg in
100mL normal saline) was given.
2. Intervention protocol
A gastric distention volume of 1000 mLs of water containing 5
drops of simethicone was ingested by the patient immediately
prior to capsule ingestion. The patient swallowed the capsule
with water ad libitum in the sitting position and subsequently
adopted the supine position to allow examination to com-
mence. MACEwas performed by a single operator (MFH) using
a handheld magnet (Navi Controller, Intromedic Ltd). Holding
the magnet over the abdominal wall, the capsule could be ro-
tated along its longitudinal axis to obtain close-up images of
the gastric mucosa or the lumen by altering the polarity of
the magnet with pronation and supination of the wrist. Move-
ment of the magnet in a longitudinal or transverse direction
across the abdominal wall was used to achieve subtle move-
ments of the capsule within the dependent pool of water. Lar-
ger movements of water were used to wash the capsule from
one area to another by positional change of the patient from
supine to the right lateral position, occasionally using the left
lateral position if orientation of the capsule within the stom-
ach was proving difficult.
Once enough imaging had been acquired to allow orientation
within the stomach, the maneuvers described were used to try
and drag the capsule into the antrum and orientate it toward
the pylorus. Thereafter, a variety of approaches were used to as-
sist transpyloric passage, most commonly involving the patient
leaning toward the right lateral position and the magnet held
over the right lateral chest wall or posteriorly as far as the verteb-
ral column. If the capsule failed to pass through the pylorus using
magnetic control, within the allotted time limit of 30 minutes,
the patient transferred to the relevant section of the control pro-
tocol.
Analysis
Based on the available literature and our local data, assuming a
CECR of 70% using our standard (control) protocol, 60 patients
were required per group to be able to detect a 20% improvement
in small bowel (CECR) with a 5% two-sided significance level, 80%
power. Quantitative data are summarized with parametric statis-
tics, the mean and standard deviation or with non-parametric
statistics, the median and interquartile range. The unpaired t
test was used to compare age between the two study groups
and the χ² test was used to compare sex and indication for small
bowel capsule endoscopy between study groups. First pyloric
view and gastric transit time were not normally distributed and
thus the MannWhitney test was used to compare the differences
in these variables between the two groups. Gastric distention and
mucosal visualisation (as measured on a 1–4 scale) between the
two groups was also compared using a Mann Whitney test, al-
though we must highlight there are some limitations of using
this test when there are only four possible outcomes to compare.
Small bowel transit time between the two groups was compared
using an unpaired t test. Linear regression was used to assess the
correlation between BMI or waist-hip ratio and gastric transit
time. An unpaired t test was used to assess the correlation be-
tween BMI or waist-hip ratio and CECR. The diagnostic yield,
CECR and patient willingness to undergo a repeat procedure
weremeasured as a simple “yes” or “no” and thus were examined
using Fisher’s exact test.
The small bowel capsule endoscopy videos were read and report-
ed in the conventional manner, which included annotation of the
anatomical landmarks (first gastric, duodenal and cecal images),
by one of two experienced capsule endoscopists (K.D, M.E.M).
One individual (M.E.M) studied all gastric imaging, assigned a
score (adapted from that used by Eliakim et al. 1: excellent; 2:
good; 3: fair; 4: poor) [21] for both clarity of the gastric mucosa
images and distension of the gastric lumen and also marked the
first image seen during the examination of the pylorus. All re-
views were done in random order and blinded to the protocol as-
signed.
Outcome measures
The primary outcome measure for the effect of magnetic control
on transpyloric transit of the capsule was CECR. Secondary out-
come measures were gastric mucosal clarity, gastric distension,
relationship of body habitus to CECR, and patient comfort scores.
Results
!
A total of 122 patients were prospectively recruited to the study
between February 2014 and February 2015.The capsule was re-
tained in the stomach for the duration of the procedure in two
patients, thus only demographic data and CECR were analysed
(●" Fig.2). Eleven patients did not return their comfort question-
naires and thus were excluded from the patient tolerance analy-
sis. No significant adverse events were recorded.
Demographic data and indications for small bowel
capsule endoscopy
Patient demographics and indications for small bowel capsule
endoscopy are shown in●" Table1. Demographic data and CECR
from 122 patients and full data from 120 patients were submit-
ted for final analysis (34 men, mean (SD) age 49.6±17.8 years,
range 20–85 years). There was no significant difference in age
(P=0.86), sex (P=0.55), indication for small bowel capsule endos-
 134 patients undergoing SBCE between Feb 14 – Feb 15 
invited to participate. 
122 patients recruited to the study and randomised to 2 groups
STANDARD PROTOCOL
Prior to CE 61 patients
INTERVENTIONAL PROTOCOL
Prior to CE 61 patients
Data analysed in 61 patients
▪ Full data obtained in 60 
 patients
▪ Demographic data only used 
 due to gastric retention of 
 capsule in 1
Data analysed in 61 patients
▪ Full data obtained in 60 
 patients
▪ Demographic data only used 
 due to gastric retention of 
 capsule in 1
12 patients who refused to 
consent to the study were 
excluded 
Fig.2 Study flow diagram.
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copy (P=0.58), BMI (P=0.37) or waist-hip ratio (P=0.53) between
the two groups (●" Table1.) All but one patient (in the interven-
tion group) were ambulatory outpatients at the time of the pro-
cedure.
Transit times, CECRs and adverse events
The overall CECR for all study patients was 87.6%, with a median
gastric transit time of 35.5 minutes (12.5–65.0) and mean small
bowel transit time of 276.8 (±132) minutes. No significant differ-
ence in esophageal transit time, CECR or small bowel transit time
was noted between the two groups (P=0.54, P=0.39 and P=0.42
respectively). However, the pylorus was visualized in a signifi-
cantly shorter time in the intervention group (P=0.03), but this
did not impact pyloric transit because there was no significant
difference in overall gastric transit time between the two groups
(P=0.12) (●" Table2). Gastric mucosal clarity and distention were
graded significantly better in the intervention group based on
the 1–4 scale used (P<0.0001 and P<0.0001 respectively), these
data are further illustrated in●" Table3.
Subanalysis of the intervention group showed that in 23 (37.7%)
procedures, the capsule could be manipulated into the duode-
num under magnetic control within the 30-minute timeframe.
There was no significant association between BMI and CECR (P=
0.51) or waist-hip ratio and CECR (P=0.94). Similarly, there was
no significant association between BMI and gastric transit time,
assessed using linear regression, (R2 0.002) or waist-hip ratio
and gastric transit time (R2 5.987). There were no known cases
of capsule retention or serious adverse events in any of the study
participants.
Magnetic steering and gastric visibility
After ingestion, the capsule was commonly propelled to a depen-
dent area along the greater curvature. Manipulation of the exter-
nal magnet at the level of the xiphisternum with the patient in
the supine position could affect tilting and rotational movements
of the capsule in order to determine the location of the capsule
and the direction of the gastric antrum (●" Fig.3) Right lateral
movement of the magnetic controller could direct the capsule to
the gastric antrum in some cases, whereas a change to the right
lateral position was required in some participants. Once the py-
lorus was visualized, further movements with the external mag-
net over the epigastrium, right upper quadrant, and back (de-
pending on body habitus) could bring the pylorus directly in
view. Manipulation of the capsule depended on a complex as-
sessment of the participant’s body habitus, degree of gastric dis-
tention and likely surface anatomy of the stomach in varying po-
sitions, together with fine movements of the external magnet
and interpretation of images received to the iPad viewer.
Patient tolerance
Patients completed a numeric rating scale questionnaire before
the procedure documenting their current and anticipated proce-
dural pain and discomfort on a 1–10 scale (0=no pain/discom-
fort, 10=worst pain/discomfort ever). After the procedure they
were required to document their actual pain, discomfort, and dis-
tress during the procedure on the same 1–10 scale. Finally each
participant was asked whether he or she would consider under-
going a repeat procedure. Therewere no significant differences in
procedural pain, discomfort or distress between the two groups
(●" Table4). 98% of participants in each groupwere willing to un-
dergo a repeat procedure if necessary.
Table 1 Patient demographics and indications for small bowel capsule
endoscopy.
Group
Control Intervenion
Number 61 61
Mean (SD) age, years 49.5 ± 18.1 49.5 ±17.8
Sex
Men 15 19
Women 45 42
Indication for CE (number (%))
OGIB or IDA 11 (18) 14 (23)
Abdominal pain and/or diarrhoea 31 (52) 26 (43)
Known Crohn’s disease 6 (10) 13 (21)
Coeliac disease 9 (15) 7 (11)
Polyposis syndromes 1 (2) 0 (0)
Other 2 (3) 1 (2)
Mean BMI (SD) 29 ±9.5 27 ±5.4
MeanWaist-Hip Ratio (SD) 0.89 ±0.15 0.90 ±0.08
SD, standard deviation; CE, capsule endoscopy; OGIB, obscure gastrointestinal
bleeding; IDA, iron deficiency anemia; BMI, body mass index
Table 2 Transit times, CECRs and adverse events.
Group
Control Intervention P value
Median OTT (IQR) (sec) 19 (10–34) 19 (13–25) 0.54
Median first pyloric
image (IQR) (min)
8 (3–25) 5 (3–10) 0.03
Median GTT (IQR)
(min)
23 (13–66) 55 (13–64) 0.12
Mean SBTT (SD) (min) 327 (±127) 317 (±128) 0.42
CECR (%) 87 89 0.39
Gastric mucosal clarity
(1–4 scale)
3 (2–3) 1 (1–2) < 0.0001
Gastric distention
(1–4 scale)
3 (3–4) 2 (1–3) < 0.0001
Diagnostic yield (%) 31 36 0.70
OTT, esophageal transit time; IQR, interquartile range; sec, seconds; min, minutes;
GTT, gastric transit time; SBTT, small bowel transit time; CECR, capsule endoscopy
completion rate
Table 3 Grading of gastric mucosal clarity and distension.
No.of patients
Control Group Intervention
Group
Gastric mucosal
clarity Score (1–4)
1 14 33
2 16 23
3 20 3
4 11 2
Gastric distension
score (1–4)
1 6 28
2 6 15
3 33 15
4 16 3
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Discussion
!
Magnetic control does not appear to be clinically useful in im-
proving CECR as a tool to assist in small bowel capsule endoscopy
and this was not affected by body habitus. However, the more ra-
pid identification of the pylorus suggests that a magnet can exert
a degree of control that allows endoscopist orientation in the
stomach and which is likely to be clinically useful for gastric cap-
sule endoscopy. Gastric preparation with a liter of ingested water
containing simethicone offers better gastric mucosal clarity and
distension than a 200-mL volume. It follows that a clean, ade-
quately distended stomach is an important aspect of successful
MACE, allowing the operator to identify gastric landmarks more
easily and thus manipulate the capsule more effectively to
achieve the required end. Importantly, MACE is a procedure that
induces no measurable pain, discomfort or distress in patients.
Further studies of control and preparation are needed to under-
stand the potential of MACE as a noninvasive upper gastrointes-
tinal diagnostic tool.
After ingestion, the capsule commonly dropped to the dependent
part of the distal gastric body and could be manipulated to view
both the antropyloric region and upper gastric body simulta-
neously. As with the study by Rey et al. using the Siemens elec-
tromagnetic guidance system, the pylorus was readily identified
andwhile progress could bemade towards it, it could not be done
sufficiently quickly to avoid posterior displacement by powerful
antropyloric contractions. [7] Efforts to do so were further ham-
pered by the need to place the magnet behind the patient to at-
tempt to pull the capsule along the superoposterior axis in which
the antroduodenum tends to lie. [22] Therefore as a tool to en-
hance GTT to optimize small bowel examination, it does not ap-
pear to be better than a standard protocol using prokinetic
agents. For the purposes of gastric examination, however, reten-
tion of the capsule is desirable and the antropyloric region, a
common site for pathology, was well visualized (●" Fig.4). Fur-
thermore, peristaltic contractions could, of course, be attenuated
using anticholinergic agents such as hyoscine [23, 24]. Whether a
combination of a promotility agent and magnetic steering could
be used together to enhance pyloric transit of the capsule would
require further research.
Strength of attraction diminishes exponentially with increasing
distance between magnets and several studies have suggested
that this might hamper MACE in obese patients. [22,25,26] How-
ever, because magnetic control failed to offer any advantage over
a standard protocol when using CECR as themain outcomemeas-
ure, it seems unlikely that this question has been adequately ad-
Direction of movement
of the capsule
Views obtained by the capsule
on greater curve
Views obtained by the capsule
in antral position
Cross section optaining view
of greater curve
Posterior
Anterior 
abdominal wall
Fig.3 Schematic of MACE maneuvers.
Table 4 Patient tolerance.Group
Control Intervention P value
Pre-procedural discomfort
median (IQR)
1 (1–3) 1 (0–3) 0.90
Pre-procedural pain
median (IQR)
0 (0–2.8) 0 (0–3) 0.98
Expected discomfort
median (IQR)
2 (0–4) 2 (0–3.8) 0.98
Expected pain
median (IQR)
2 (0–4) 1 (0–3) 0.42
Procedural pain
median (IQR)
0 (–) 0 (–) 0.58
Procedural discomfort
median (IQR)
0 (0–1) 0 (–) 0.43
Procedural distress
median (IQR)
0 (–) 0 (–) 0.54
Repeat procedure (%)* 98 98
IQR, interquartile range
* Willingness to undergo a repeat procedure.
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Fig.4 a Longitudinal view of the gastric body and
lesser curve. b Gastric antrum. c Pre-pyloric erosion.
d Angioectasia in the cardia. e NSAID-related ero-
sive gastropathy. f Fundic gland polyps. g Pancreatic
rest.
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dressed and further study is needed using different markers of
control.
Inflation of the stomach during esophagogastroduodenoscopy al-
lows the endoscopist to distend the stomach and flatten rugal
folds, maximizing the chances of visualising the whole gastric
mucosal surface, therefore minimizing the risk of missed pathol-
ogy. Such a facility is not an option in a remote technology like
capsule endoscopy, but may be afforded indirectly by the inges-
tion of water or gas-producing substances. Our study shows that
ingestion of a liter of water significantly improves gastric muco-
sal clarity and distension compared to a 200-mL volume. Other
studies have empirically used water volumes of 300mL [9] and
1300mL (in three divided doses over 75 minutes) [7,27] alone,
or 500mL [25] and 1000mL [26] with gas-producing substances.
The addition of simethicone as an anti-foaming agent may have
contributed to opacity of the gastric content in other studies
[25,26] but appears to have been used in larger doses than in
our protocol. Further investigation is needed to determine the
optimal preparation, but the evidence from this study is that
higher ingestion volumes improve the distension and visibility
of the gastric mucosa and, thus, the overall quality of the exami-
nation.
The Siemens guidance system generates a magnetic field of vary-
ing strength and capsule movement is controlled using joysticks.
It may, therefore, allow more subtle control than is afforded by a
handheld magnet, which is reliant on the operator adjusting the
distance of the magnet from, and location over, the skin surface.
The magnet weighs 1.2kg, so subtlety of control probably dimin-
ishes as the arm fatigues. However, endoscopists have long been
used to learning complex procedures that require high levels of
manual dexterity and the attraction of a handheld magnet is sim-
plicity of operation, portability and comparatively minimal cost.
Conclusions
!
Manipulation of a capsule endoscope in the stomach using mag-
netic steering is feasible but it does not overcome pyloric contrac-
tions to enhance gastric emptying or improve CECR. Improved
gastric mucosal clarity and distension are observed using higher
volumes of ingested water and the addition of simethicone. Fur-
ther work is recommended to explore the potential of this novel
technology.
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